US Stock MarketDetailed Quotes

LRMR Larimar Therapeutics

Watchlist
  • 3.820
  • +0.040+1.06%
Trading Dec 26 10:40 ET
243.74MMarket Cap-3.32P/E (TTM)

Larimar Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
76.65%18.26M
155.71%24.6M
119.12%16.73M
14.32%41.76M
35.66%14.16M
21.45%10.34M
10.74%9.62M
-14.07%7.64M
-27.62%36.53M
14.89%10.44M
Selling and administrative expenses
15.74%4.35M
31.30%4.92M
23.41%3.8M
14.76%14.09M
9.10%3.51M
28.08%3.75M
23.07%3.75M
-0.19%3.08M
1.72%12.28M
15.28%3.22M
-General and administrative expense
15.74%4.35M
31.30%4.92M
23.41%3.8M
14.76%14.09M
9.10%3.51M
28.08%3.75M
23.07%3.75M
-0.19%3.08M
1.72%12.28M
15.28%3.22M
Research and development costs
111.37%13.92M
235.01%19.68M
183.63%12.94M
14.10%27.67M
47.52%10.65M
17.97%6.59M
4.09%5.88M
-21.43%4.56M
-36.84%24.25M
14.72%7.22M
Operating profit
-76.65%-18.26M
-155.71%-24.6M
-119.12%-16.73M
-14.32%-41.76M
-35.66%-14.16M
-21.45%-10.34M
-10.74%-9.62M
14.07%-7.64M
27.62%-36.53M
-14.89%-10.44M
Net non-operating interest income expense
Other net income (expense)
116.86%2.77M
137.00%2.97M
87.22%2.08M
310.67%4.81M
15.29%1.17M
560.62%1.28M
6,170.00%1.25M
2,083.93%1.11M
784.80%1.17M
2,212.50%1.01M
Other non- operating income (expenses)
116.86%2.77M
137.00%2.97M
87.22%2.08M
310.67%4.81M
15.29%1.17M
560.62%1.28M
6,170.00%1.25M
2,083.93%1.11M
784.80%1.17M
2,212.50%1.01M
Income before tax
-71.00%-15.5M
-158.51%-21.63M
-124.55%-14.65M
-4.51%-36.95M
-37.86%-12.99M
-8.94%-9.06M
3.47%-8.37M
27.03%-6.53M
30.18%-35.36M
-3.19%-9.43M
Income tax
Net income
-71.00%-15.5M
-158.51%-21.63M
-124.55%-14.65M
-4.51%-36.95M
-37.86%-12.99M
-8.94%-9.06M
3.47%-8.37M
27.03%-6.53M
30.18%-35.36M
-3.19%-9.43M
Net income continuous Operations
-71.00%-15.5M
-158.51%-21.63M
-124.55%-14.65M
-4.51%-36.95M
-37.86%-12.99M
-8.94%-9.06M
3.47%-8.37M
27.03%-6.53M
30.18%-35.36M
-3.19%-9.43M
Minority interest income
Net income attributable to the parent company
-71.00%-15.5M
-158.51%-21.63M
-124.55%-14.65M
-4.51%-36.95M
-37.86%-12.99M
-8.94%-9.06M
3.47%-8.37M
27.03%-6.53M
30.18%-35.36M
-3.19%-9.43M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-71.00%-15.5M
-158.51%-21.63M
-124.55%-14.65M
-4.51%-36.95M
-37.86%-12.99M
-8.94%-9.06M
3.47%-8.37M
27.03%-6.53M
30.18%-35.36M
-3.19%-9.43M
Basic earnings per share
-14.29%-0.24
-78.95%-0.34
-80.00%-0.27
38.69%-0.84
-38.10%-0.29
43.24%-0.21
59.57%-0.19
69.39%-0.15
53.56%-1.37
58.00%-0.21
Diluted earnings per share
-14.29%-0.24
-78.95%-0.34
-80.00%-0.27
38.69%-0.84
-38.10%-0.29
43.24%-0.21
59.57%-0.19
69.39%-0.15
53.56%-1.37
58.00%-0.21
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 76.65%18.26M155.71%24.6M119.12%16.73M14.32%41.76M35.66%14.16M21.45%10.34M10.74%9.62M-14.07%7.64M-27.62%36.53M14.89%10.44M
Selling and administrative expenses 15.74%4.35M31.30%4.92M23.41%3.8M14.76%14.09M9.10%3.51M28.08%3.75M23.07%3.75M-0.19%3.08M1.72%12.28M15.28%3.22M
-General and administrative expense 15.74%4.35M31.30%4.92M23.41%3.8M14.76%14.09M9.10%3.51M28.08%3.75M23.07%3.75M-0.19%3.08M1.72%12.28M15.28%3.22M
Research and development costs 111.37%13.92M235.01%19.68M183.63%12.94M14.10%27.67M47.52%10.65M17.97%6.59M4.09%5.88M-21.43%4.56M-36.84%24.25M14.72%7.22M
Operating profit -76.65%-18.26M-155.71%-24.6M-119.12%-16.73M-14.32%-41.76M-35.66%-14.16M-21.45%-10.34M-10.74%-9.62M14.07%-7.64M27.62%-36.53M-14.89%-10.44M
Net non-operating interest income expense
Other net income (expense) 116.86%2.77M137.00%2.97M87.22%2.08M310.67%4.81M15.29%1.17M560.62%1.28M6,170.00%1.25M2,083.93%1.11M784.80%1.17M2,212.50%1.01M
Other non- operating income (expenses) 116.86%2.77M137.00%2.97M87.22%2.08M310.67%4.81M15.29%1.17M560.62%1.28M6,170.00%1.25M2,083.93%1.11M784.80%1.17M2,212.50%1.01M
Income before tax -71.00%-15.5M-158.51%-21.63M-124.55%-14.65M-4.51%-36.95M-37.86%-12.99M-8.94%-9.06M3.47%-8.37M27.03%-6.53M30.18%-35.36M-3.19%-9.43M
Income tax
Net income -71.00%-15.5M-158.51%-21.63M-124.55%-14.65M-4.51%-36.95M-37.86%-12.99M-8.94%-9.06M3.47%-8.37M27.03%-6.53M30.18%-35.36M-3.19%-9.43M
Net income continuous Operations -71.00%-15.5M-158.51%-21.63M-124.55%-14.65M-4.51%-36.95M-37.86%-12.99M-8.94%-9.06M3.47%-8.37M27.03%-6.53M30.18%-35.36M-3.19%-9.43M
Minority interest income
Net income attributable to the parent company -71.00%-15.5M-158.51%-21.63M-124.55%-14.65M-4.51%-36.95M-37.86%-12.99M-8.94%-9.06M3.47%-8.37M27.03%-6.53M30.18%-35.36M-3.19%-9.43M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -71.00%-15.5M-158.51%-21.63M-124.55%-14.65M-4.51%-36.95M-37.86%-12.99M-8.94%-9.06M3.47%-8.37M27.03%-6.53M30.18%-35.36M-3.19%-9.43M
Basic earnings per share -14.29%-0.24-78.95%-0.34-80.00%-0.2738.69%-0.84-38.10%-0.2943.24%-0.2159.57%-0.1969.39%-0.1553.56%-1.3758.00%-0.21
Diluted earnings per share -14.29%-0.24-78.95%-0.34-80.00%-0.2738.69%-0.84-38.10%-0.2943.24%-0.2159.57%-0.1969.39%-0.1553.56%-1.3758.00%-0.21
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Heat List
US
Overall
Symbol
Price
% Chg

No Data